?url_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.aufirst=F&rft.au=Sundquist%2C+F&rft.aulast=Sundquist&rft.date=10+March+2022&rft.atitle=A+Phase+II+Trial+of+a+Personalized%2C+Dose-Intense+Administration+Schedule+of+177Lutetium-DOTATATE+in+Children+With+Primary+Refractory+or+Relapsed+High-Risk+Neuroblastoma%E2%80%93LuDO-N&rft.volume=10&rft.title=Frontiers+in+Pediatrics&rft.issn=2296-2360&rft.genre=article